Delivery Order SPE2DB24D1205-SPE2DB25FCYAE
Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,308.91 firm fixed-price contract is for the delivery of 4,567,644,043 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,140.98, is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 24, 2025. There is no set-aside designation, indicating open competition for this award....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules, with a firm fixed price of $1,849.04 and a performance period ending on April 21, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,823.76, is for the supply of 100 capsules of the medication Vyvanse (60 mg). It is a firm-fixed-price delivery order contract with a performance period through June 30, 2025. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $4,604.21 and a completion date of July 3, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. The contract is not set aside for any specific business type....
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,596.18 firm fixed price contract is for the delivery of 100 units of the 20 mg capsule version of the drug Vyvanse. The contract has an ultimate completion date of July 17, 2025 and is not set aside for any special designation. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 100 units of the prescription medication Vyvanse 60 mg capsules. The contract has a firm fixed price of $1,668.36 and a completion date of May 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract...
- This is a $1,404.05 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of June 30, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,381.58 firm fixed-price contract is for the delivery of 4,567,168,394 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a firm fixed-price of $3,604.44 and a performance period through May 7, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYAEDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules, with a firm fixed price of $2,599.66 and a completion date of June 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs and other government agencies through December 2026.
Generated 9/24/25, 10:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/25/25 |